Your browser doesn't support javascript.
loading
Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG Vectors.
Hart, Bryan E; Asrican, Rose; Lim, So-Yon; Sixsmith, Jaimie D; Lukose, Regy; Souther, Sommer J R; Rayasam, Swati D G; Saelens, Joseph W; Chen, Ching-Ju; Seay, Sarah A; Berney-Meyer, Linda; Magtanong, Leslie; Vermeul, Kim; Pajanirassa, Priyadharshini; Jimenez, Amanda E; Ng, Tony W; Tobin, David M; Porcelli, Steven A; Larsen, Michelle H; Schmitz, Joern E; Haynes, Barton F; Jacobs, William R; Lee, Sunhee; Frothingham, Richard.
Afiliación
  • Hart BE; Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Asrican R; Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Lim SY; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Sixsmith JD; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Lukose R; Howard Hughes Medical Institute and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, USA.
  • Souther SJ; Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Rayasam SD; Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Saelens JW; Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA.
  • Chen CJ; Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Seay SA; Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Berney-Meyer L; Howard Hughes Medical Institute and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, USA.
  • Magtanong L; Howard Hughes Medical Institute and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, USA.
  • Vermeul K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Pajanirassa P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Jimenez AE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Ng TW; Howard Hughes Medical Institute and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, USA.
  • Tobin DM; Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA.
  • Porcelli SA; Howard Hughes Medical Institute and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, USA.
  • Larsen MH; Howard Hughes Medical Institute and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, USA.
  • Schmitz JE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Haynes BF; Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Jacobs WR; Howard Hughes Medical Institute and Department of Microbiology and Immunology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, USA.
  • Lee S; Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Frothingham R; Human Vaccine Institute and Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA richard.frothingham@duke.edu.
Clin Vaccine Immunol ; 22(7): 726-41, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25924766
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Productos del Gen gag / Proteína gp120 de Envoltorio del VIH / Inestabilidad Genómica / Mycobacterium bovis / Antígenos Virales Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Clin Vaccine Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portadores de Fármacos / Productos del Gen gag / Proteína gp120 de Envoltorio del VIH / Inestabilidad Genómica / Mycobacterium bovis / Antígenos Virales Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Clin Vaccine Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos